Stericycle (NASDAQ:SRCL) Given New $50.00 Price Target at Truist Financial

Stericycle (NASDAQ:SRCL) had its price target cut by Truist Financial from $57.00 to $50.00 in a research note released on Monday morning, Benzinga reports. They currently have a hold rating on the business services provider’s stock.

A number of other equities research analysts have also recently weighed in on the stock. Wells Fargo & Company lifted their price objective on shares of Stericycle from $40.00 to $48.00 and gave the company an underweight rating in a research note on Friday, March 1st. Stifel Nicolaus lifted their price objective on shares of Stericycle from $70.00 to $75.00 and gave the company a buy rating in a research note on Thursday, February 29th. StockNews.com cut shares of Stericycle from a buy rating to a hold rating in a research note on Tuesday, April 2nd. Royal Bank of Canada restated an outperform rating and set a $69.00 price objective on shares of Stericycle in a research note on Thursday, March 7th. Finally, Robert W. Baird cut their price objective on shares of Stericycle from $62.00 to $55.00 and set a neutral rating on the stock in a research note on Friday, April 26th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Stericycle currently has an average rating of Hold and a consensus target price of $59.40.

Stericycle Stock Performance

Shares of SRCL opened at $44.30 on Monday. Stericycle has a 1 year low of $37.78 and a 1 year high of $57.06. The company has a market cap of $4.11 billion, a price-to-earnings ratio of -201.36, a price-to-earnings-growth ratio of 2.44 and a beta of 1.09. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a fifty day moving average of $51.18 and a 200-day moving average of $48.28.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The company had revenue of $664.90 million during the quarter, compared to the consensus estimate of $676.42 million. During the same quarter in the previous year, the company posted $0.49 earnings per share. The company’s revenue for the quarter was down 2.8% compared to the same quarter last year. As a group, equities analysts anticipate that Stericycle will post 2.32 earnings per share for the current year.

Institutional Investors Weigh In On Stericycle

Several hedge funds and other institutional investors have recently bought and sold shares of SRCL. Principal Securities Inc. bought a new stake in Stericycle in the fourth quarter worth about $41,000. GAMMA Investing LLC raised its position in Stericycle by 170.9% in the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock worth $43,000 after acquiring an additional 516 shares in the last quarter. TFO Wealth Partners LLC raised its position in Stericycle by 22,325.0% in the fourth quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after acquiring an additional 893 shares in the last quarter. Exchange Traded Concepts LLC raised its position in Stericycle by 87.5% in the third quarter. Exchange Traded Concepts LLC now owns 1,001 shares of the business services provider’s stock worth $45,000 after acquiring an additional 467 shares in the last quarter. Finally, Ramirez Asset Management Inc. purchased a new position in Stericycle in the 3rd quarter worth about $45,000. 98.82% of the stock is currently owned by institutional investors.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.